home / stock / bcli / bcli short
Short Information | Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 4,167,297 |
Total Actual Volume | 21,212,222 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 208,365 |
Average Short Percentage | 22.11% |
Is there a BCLI Short Squeeze or Breakout about to happen?
See the BCLI Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $0.515 | $0.545 | $0.5563 | $0.515 | 189,970 | 49,602 | 26.11% |
04-23-2024 | $0.536 | $0.525 | $0.5588 | $0.51 | 166,413 | 18,623 | 11.19% |
04-22-2024 | $0.538 | $0.5401 | $0.5823 | $0.5109 | 367,454 | 98,093 | 26.7% |
04-19-2024 | $0.5 | $0.532 | $0.61 | $0.4523 | 1,007,163 | 247,608 | 24.58% |
04-18-2024 | $0.5634 | $0.5143 | $0.59 | $0.4512 | 1,080,653 | 241,183 | 22.32% |
04-17-2024 | $0.525 | $0.5408 | $0.5877 | $0.525 | 528,799 | 153,740 | 29.07% |
04-16-2024 | $0.5181 | $0.5271 | $0.57 | $0.45 | 628,134 | 75,876 | 12.08% |
04-15-2024 | $0.5918 | $0.5487 | $0.6 | $0.537 | 594,675 | 125,783 | 21.15% |
04-12-2024 | $0.5847 | $0.584 | $0.62 | $0.583 | 264,997 | 63,336 | 23.9% |
04-11-2024 | $0.59 | $0.5771 | $0.67 | $0.5353 | 1,392,123 | 339,776 | 24.41% |
04-10-2024 | $0.63 | $0.6015 | $0.6353 | $0.5805 | 1,099,787 | 177,336 | 16.12% |
04-09-2024 | $0.73 | $0.5825 | $0.74 | $0.57 | 4,721,544 | 690,316 | 14.62% |
04-08-2024 | $0.683 | $0.73 | $0.75 | $0.6525 | 2,863,445 | 295,112 | 10.31% |
04-05-2024 | $0.651 | $0.651 | $0.685 | $0.6298 | 624,560 | 176,914 | 28.33% |
04-04-2024 | $0.6748 | $0.675 | $0.7165 | $0.65 | 717,358 | 298,876 | 41.66% |
04-03-2024 | $0.71 | $0.6893 | $0.7199 | $0.6671 | 943,277 | 182,526 | 19.35% |
04-02-2024 | $0.74 | $0.719 | $0.7488 | $0.67 | 613,110 | 157,355 | 25.67% |
04-01-2024 | $0.6085 | $0.7399 | $0.75 | $0.5895 | 1,460,038 | 405,618 | 27.78% |
03-28-2024 | $0.58 | $0.5647 | $0.5999 | $0.484 | 649,965 | 108,075 | 16.63% |
03-27-2024 | $0.6597 | $0.6002 | $0.6863 | $0.51 | 1,298,757 | 261,549 | 20.14% |
News, Short Squeeze, Breakout and More Instantly...
Brainstorm Cell Therapeutics Inc. Company Name:
BCLI Stock Symbol:
NASDAQ Market:
Brainstorm Cell Therapeutics Inc. Website:
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn PR Newswire Bob Dagher , MD, Promoted to Chief Medical Officer Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of Directors NE...
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule PR Newswire NEW YORK , April 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI, "the Company"), a leading developer of cellular therapies for neurodegener...
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS PR Newswire NurOwn treatment resulted in a positive impact on important CSF biomarkers relevant to ALS compared to placebo. Significant changes ...